Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,654 | 9,077 | 7,832 | 17,909 | 18,555 |
| Receivables | 10,495 | 6,201 | 3,095 | 5,546 | 4,230 |
| Inventories | 15,224 | 11,168 | 9,551 | 8,602 | 7,468 |
| TOTAL | $34,729 | $27,445 | $21,510 | $33,165 | $30,473 |
| Non-Current Assets | |||||
| PPE Net | 9,770 | 10,098 | 10,426 | 10,230 | 10,544 |
| Intangibles | 6,341 | 6,341 | 6,341 | 6,634 | 6,634 |
| Other Non-Current Assets | 19,879 | 2,616 | 2,618 | 2,687 | 2,693 |
| TOTAL | $35,990 | $19,055 | $19,386 | $19,551 | $19,871 |
| Total Assets | $70,719 | $46,500 | $40,896 | $52,716 | $50,343 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 295 | 251 | 311 | 471 | 503 |
| Accounts payable and accrued liabilities | 3,609 | 1,875 | 2,447 | 1,472 | 1,724 |
| Accrued Expenses | 11,158 | 5,929 | 5,048 | 4,676 | 4,579 |
| TOTAL | $19,078 | $12,078 | $7,834 | $6,654 | $6,843 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,355 | 3,578 | 3,562 | 15,489 | 15,532 |
| Deferred Revenues | 13 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 3,179 | 711 | 522 | 376 | 751 |
| TOTAL | $6,547 | $4,305 | $4,102 | $15,887 | $16,309 |
| Total Liabilities | $25,625 | $16,382 | $11,936 | $22,542 | $23,152 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,013,915 | 1,013,915 | 1,013,915 | 1,013,915 | 1,013,915 |
| Common Shares | 1,014 | 1,014 | 1,014 | 1,014 | 1,014 |
| Retained earnings | -120,422 | -135,356 | -136,498 | -135,269 | -138,239 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $45,095 | $30,117 | $28,960 | $30,175 | $27,191 |
| Total Liabilities And Equity | $70,719 | $46,500 | $40,896 | $52,716 | $50,343 |